1. Protein Tyrosine Kinase/RTK Apoptosis
  2. c-Met/HGFR Apoptosis
  3. c-Met-IN-22

c-Met-IN-22(compound 51am) 是一种口服有效的 c-Met 抑制剂,IC50 值是 2.54 nM。c-Met-IN-22 具有抗增殖活性和抗肿瘤活性。c-Met-IN-22 可以诱导细胞凋亡(apoptosis)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

c-Met-IN-22 Chemical Structure

c-Met-IN-22 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

c-Met-IN-22 (compound 51am) is an orally active inhibitor against c-Met with an IC50 value of 2.54 nM. c-Met-IN-22 has antiproliferative and antitumor activities. c-Met-IN-22 induces cell apoptosis[1].

IC50 & Target[1]

c-Metwild type

2.54 nM (IC50)

c-MetH1094R

93.6 nM (IC50)

c-MetD1228H

29.4 nM (IC50)

c-MetY1230H

45.8 nM (IC50)

c-MetY1235D

54.2 nM (IC50)

c-MetM1250T

26.5 nM (IC50)

c-Metkit

4.94 nM (IC50)

c-MetRon

3.83 nM (IC50)

c-MetPDGFRα

425 nM (IC50)

c-MetPDGFRβ

513 nM (IC50)

c-MetVEGFR-2

527 nM (IC50)

c-MetFit-3

6.12 nM (IC50)

c-MetFit-4

276 nM (IC50)

体外研究
(In Vitro)

c-Met-IN-22 在细胞 MNK-45,A-549,HT-29,MDA-MB-231,HUVEC 和 FHC 中具有抗增殖活性,IC50 值分别为0.092,0.83,0.68,3.94,2.54 和 8.63 μM[1]
c-Met-IN-22 对突变体 H1094R,D1228H,Y1230H,Y1235D 和 M1250T 仍具有抑制作用,IC50 值分别为 93.6,29.4,45.8,54.2 和 26.5 nM[1]
c-Met-IN-22(0,2.5, 5.0 和 10.0 μM; 24 h)具有剂量依赖性的抑制 MKN-45 中 c-Met 的磷酸化[1]
c-Met-IN-22(0.4,0.8 和 1.2  μM;24 h)诱导 MNK-45 细胞周期在 G2 阶段的阻滞和细胞凋亡,且具有剂量依赖性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[1]

Cell Line: MNK- 45 cells
Concentration: 0.4, 0.8, 1.2 μM
Incubation Time: 24 h
Result: Induced cell apoptosis in a dose-dependent manner.

Cell Cycle Analysis[1]

Cell Line: MNK- 45 cells
Concentration: 0.4, 0.8, 1.2 μM
Incubation Time: 24 h
Result: Induced cell cycle arrest at G2 phase in a dose-dependent manner.

Western Blot Analysis[1]

Cell Line: MNK- 45 cells
Concentration: 0, 2.5, 5, 10 μM
Incubation Time: 24 h
Result: Inhibited c-Met phosphorylation in a dose-dependent manner.
体内研究
(In Vivo)

c-Met-IN-22(10mg/kg;口服;单剂量)在 BALB/c 小鼠中表现出良好的口服生物利用度(F=69%),清除半衰期是 5.6 小时,清除率是 0.87L/h•kg [1]
c-Met-IN-22(1.5mg/kg,静脉注射)在 BALB/c 小鼠中的清除半衰期是 3.2 小时[1]

c-Met-IN-22 在 BALB/c 小鼠体内的药代动力学分析[1]

Route Dose (mg/kg) AUC0→∞ (μg·h/mL) T1/2 (h) Tmax (h) Cmax (ng/mL) Cl (L/h·kg) F (%)
i.v. 1.5mg/kg 2.5 3.2 / 552 0.6 /
p.o. 10mg/kg 11.5 5.6 4.1 1756 / 69

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Pharmacokinetic Analysis in BALB/c mice
Dosage: p.o.10 mg/kg; i.v. 1.5 mg/kg
Administration: Intravenous (i.v.) injection, Oral administration (p.o.)
Result: Characterised good maximum concentration, plasma exposure and elimination half-time in pharmacokinetics.
分子量

512.74

Formula

C21H10Cl3F2N3O2S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
c-Met-IN-22
目录号:
HY-157387
需求量: